Methyl-Branched Liposomes as a Depot for Sustained Drug Delivery
Source abstract
Abstract
Inadequate drug loading and control of payload leakage limit the duration of the effect of liposomal drug carriers and may cause toxicity. Here, we report a liposome system as a depot for sustained drug delivery whose design is inspired by the low permeability of Archaeal membranes to protons and solutes. Incorporating methyl-branched phospholipids into lipid bilayers decreased payload diffusion across liposomal membranes, thereby enhancing the drug load capacity by 10-16% and reducing the release of small molecules in the first 24 h by 40-48%. The in vivo impact of this approach was demonstrated by injection at the sciatic nerve. Methyl-branched liposomes encapsulating the anesthetic tetrodotoxin (TTX) achieved markedly prolonged local anesthesia lasting up to 70 h, in comparison to the 16 h achieved with liposomes containing conventional lipids. The present work demonstrates the usefulness of methyl-branched liposomes to enhance liposomal depot systems for sustained drug delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Lipid Membrane Structure and Behavior · Supramolecular Chemistry and Complexes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, United States
Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts 02115, United States
Funding
National Institutes of Health · National Institute of General Medical Sciences
References (30)
Show source-provided references
1. 10.1038/nrd163210.1038/nrd1632 ↗
2. 10.1016/j.addr.2012.09.03710.1016/j.addr.2012.09.037 ↗
3. 10.3390/pharmaceutics902001210.3390/pharmaceutics9020012 ↗
4. 10.1016/j.addr.2020.07.01610.1016/j.addr.2020.07.016 ↗
5. 10.1016/S0168-3659(01)00248-610.1016/S0168-3659(01)00248-6 ↗
6. 10.1038/nmat296010.1038/nmat2960 ↗
7. 10.1021/acsami.9b0890110.1021/acsami.9b08901 ↗
8. 10.1021/ja806555710.1021/ja8065557 ↗
9. 10.1038/nmat298610.1038/nmat2986 ↗
10. 10.1016/j.jconrel.2014.04.04710.1016/j.jconrel.2014.04.047 ↗
11. 10.1073/pnas.87.12.457610.1073/pnas.87.12.4576 ↗
12. 10.1038/nrmicro257610.1038/nrmicro2576 ↗
13. 10.1002/ejoc.20080045210.1002/ejoc.200800452 ↗
14. 10.1073/pnas.151879111210.1073/pnas.1518791112 ↗
15. 10.1111/j.1533-2500.2005.00048.x10.1111/j.1533-2500.2005.00048.x ↗
16. 10.1021/acs.langmuir.8b0425610.1021/acs.langmuir.8b04256 ↗
17. 10.1016/S0041-0101(98)00171-810.1016/S0041-0101(98)00171-8 ↗
18. 10.1289/ehp.952710.1289/ehp.9527 ↗
19. 10.3109/0899022940905139210.3109/08990229409051392 ↗
20. 10.1097/00000542-199807000-0001910.1097/00000542-199807000-00019 ↗
21. 10.1038/s41551-021-00793-y10.1038/s41551-021-00793-y ↗
22. 10.1016/j.mattod.2016.11.01910.1016/j.mattod.2016.11.019 ↗
23. 10.1097/ALN.000000000000083310.1097/ALN.0000000000000833 ↗
24. 10.1039/C0SC00203H10.1039/C0SC00203H ↗
25. 10.1021/acs.nanolett.6b0358810.1021/acs.nanolett.6b03588 ↗
26. 10.1002/(SICI)1521-3765(20000218)6:4<645::AID-CHEM645>3.0.CO;2-A10.1002/(SICI)1521-3765(20000218)6:4<645::AID-CHEM645>3.0.CO;2-A ↗
27. Lodish H. · 2000
28. 10.1016/j.biomaterials.2014.02.01510.1016/j.biomaterials.2014.02.015 ↗
29. 10.1038/nrd322610.1038/nrd3226 ↗
30. 10.1056/NEJMsr160130710.1056/NEJMsr1601307 ↗